Combining the rigor of independent research with the speed of new technology, we are giving cannabis the science it has always deserved. To close the decades it sits behind every other crop. To read a plant's future from a single seed. To turn a result on paper into a product in the field. And to make proof useful the moment it exists. So the people who grow this plant, and build on it, can finally move as fast as their ambition.
Research and breeding raised corn yields sixfold in a century.
Cannabis is at the start of the same curve.
Foreseeding is reading what a living system will become before it unfolds, in a seed, a plant, a grow, a cultivar, a yield, a facility, and an industry. From the molecular signature to the market, Innexo turns the future of cannabis from a guess into a measurement.
Spectral fingerprinting captures the molecular signature of a single seed and turns light into measurable data. From thousands of those readings we model the plant it will become, its chemistry, its vigour, its yield, before one is ever planted.
Foreseeding works at every scale, from the molecular signature of a seed to the direction of an industry. These are the instruments that do the reading.
Founded in 2021 by Dominique van Gruisen, a farm-to-pharma translator holding a licensed R&D mandate for cannabis, Innexo turns fragmented research into validated, commercial-ready practice. The team blends cultivation, molecular farming, pharmaceutical development, and operational excellence, pairing technical depth with hands-on experience to deliver proof a client can build on.
FormerInterns at Innexo run live projects in molecular farming and cannabis research, gaining hands-on experience in contract research, product testing, and operational excellence.
Former
Former
FormerLicensed and fully instrumented for proof: climate cells, greenhouse compartments, a controlled drying room, and dedicated pathogen and pest laboratories for high-pressure testing.
INNEXO RESEARCH FACILITY · HORST-METERIK, NL
